Bioorganic and Medicinal Chemistry p. 4921 - 4931 (2003)
Update date:2022-08-05
Topics:
Saccomanni, Giuseppe
Badawneh, Muwaffag
Adinolfi, Barbara
Calderone, Vincenzo
Cavallini, Tiziana
Ferrarini, Pier Luigi
Greco, Rosamiria
Manera, Clementina
Testai, Lara
Drugs acting on β1- and β2-adrenergic receptors are widely used for the clinical management of a large number of cardiovascular and respiratory pathologies. In the last decade, the discovery of the third subtype of β receptors, the β3-adrenoceptor, gave a further pharmacological target for the development of new selective drugs. Initially, a potential therapeutic use of β3-selective agents seemed to be restricted to agonists, for the treatment of metabolic diseases, such as obesity, non-insulin-dependent diabetes, urinary frequency and incontinence. More recently, some interesting theories about a negative role played by the cardio-depressant activity of myocardial β 3-adrenoceptors in heart failure, seemed to justify a clinical use of β3-antagonists in the last phases of this cardiac disease. Following the indications deriving from previous experimental work, the β-antagonist properties of newly-synthesised (R,S)-(E)-oximeethers of 2,3-dihydro-1,8-naphthyridine and of 2,3-dihydrothiopyrano[2,3-b]pyridine were evaluated, in order to identify some useful structure-activity relationships, which might account for selectivity towards the three β-subtypes and, in particular, the β3-adrenoceptor. Among the various observations regarding possible structure-activity relationships, able to explain the pharmacodynamic patterns of the synthesised compounds on the three subtypes of β-adrenoceptors, the most significant data derived from the evaluation of the β3-blocking properties of some oximeethers of 1,8-naphthyridine derivatives. In these molecules, although the presence of the large substituents in position 7, such as 4-chloro-phenoxy- or 4-t-butyl-phenoxy groups determined a dramatic decline in both the β 1- and β2-activities, this structural characteristic had a modest influence on the β3-affinity, which was only slightly lower. Hence, this last structural requirement of oximeethers of 1,8-naphthyridine derivatives seems to represent a useful expedient to induce an appreciable selectivity towards the β3-receptor, through a markedly negative effect on the β1- and β 2-activities rather than an increase in the β 3-affinity.
View MoreContact:+86-134-5286-9121
Address:Add: Wing Tuck Commercial Centre, 177-183 Wing Lok Street, Hong Kong,
Contact:+65 9658 0999
Address:26 Sin Ming Lane, Midview City, #05-118, Singapore 573971
Shouguang Nuomeng Chemical Co., Ltd.
Contact:+86-536-5119508/18363669993
Address:Hou Zhen Industrial Park, Shouguang, Shandong, China
Contact:+86-512-69561895
Address:No.111, Building A4, 218 Xinghu Street, Suzhou Industrial Park, P. R. China
Feis International Trade Co,. Ltd
Contact:13961823444-18235944442
Address:Wuxi jiangsu
Doi:10.1081/SCC-120027259
(2004)Doi:10.1007/BF00471654
()Doi:10.1002/hc.10195
(2003)Doi:10.1246/cl.1995.829
(1995)Doi:10.1002/jlcr.2580140415
(1978)Doi:10.1016/j.tetasy.2004.01.017
(2004)